CoChat

Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections

Beck, Roy W., Riddlesworth, Tonya D. · 2018 · Annals of Internal Medicine
Cited by 26

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Letters3 April 2018Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin InjectionsRoy W. Beck, MD, PhD and Tonya D. Riddlesworth, PhDRoy W. Beck, MD, PhDJaeb Center for Health Research, Tampa, Florida (R.W.B., T.D.R.) and Tonya D. Riddlesworth, PhDJaeb Center for Health Research, Tampa, Florida (R.W.B., T.D.R.)Author, Article, and Disclosure Informationhttps://doi.org/10.7326/L17-0706 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE:The treatment group difference used to calculate a sample size is the postulated estimate of the true population value and is not intended to indicate what would be considered clinically significant, which is a common misconception. The upper limit of the 95% CI for the observed treatment group difference in HbA1c levels was 0.6%, extending beyond the projected true population value of 0.4%. We believe that a treatment group difference of 0.3% represents a meaningful shift in the HbA1c distributions, as evidenced by our finding that 73% of the CGM group achieved an HbA1c reduction of 0.5% or ...References1. Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline JP, Rayman G. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther. 2017;8:55-73. [PMID: 28000140] doi:10.1007/s13300-016-0223-6 CrossrefMedlineGoogle Scholar2. U.S. Food and Drug Administration. Summary of safety and effectiveness data: Freestyle Libre Pro Flash Glucose Monitoring System. 2016. Accessed at www.accessdata.fda.gov/cdrh_docs/pdf15/p150021b.pdf on 28 October 2017. Google Scholar Author, Article, and Disclosure InformationAffiliations: Jaeb Center for Health Research, Tampa, Florida (R.W.B., T.D.R.)Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M16-2855. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoContinuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections Roy W. Beck , Tonya D. Riddlesworth , Katrina Ruedy , Andrew Ahmann , Stacie Haller , Davida Kruger , Janet B. McGill , William Polonsky , David Price , Stephen Aronoff , Ronnie Aronson , Elena Toschi , Craig Kollman , Richard Bergenstal , and Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections Thomas Haak Metrics Cited byIMpact of flash glucose Monitoring in pEople with type 2 Diabetes Inadequately controlled with non‐insulin Antihyperglycaemic ThErapy ( IMMEDIATE ): A randomized controlled trialAcceptance and Effect of Continuous Glucose Monitoring on Discharge From Hospital in Patients With Type 2 Diabetes: Open-label, Prospective, Controlled StudyEpisodic Real-Time CGM Use in Adults with Type 2 Diabetes: Results of a Pilot Randomized Controlled TrialPatients with Type 2 Diabetes and Residual Insulin Secretory Capacity Realize Glycemic Benefits from Real-Time Continuous Glucose MonitoringChange in Hemoglobin A1c and Quality of Life with Real-Time Continuous Glucose Monitoring Use by People with Insulin-Treated Diabetes in the Landmark StudyImproved Real-World Glycemic Control With Continuous Glucose Monitoring System Predictive AlertsDiabetes in ageing: pathways for developing the evidence base for clinical guidanceContinuous Glucose Monitoring: Review of an Innovation in Diabetes ManagementGoing beyond HbA1c to understand the benefits of advanced diabetes therapiesDigitale Tools und strukturierte Prozesse verbessern Therapiequalität 3 April 2018Volume 168, Issue 7Page: 526-527KeywordsBody weightDisclosureGlucoseHbA1cHypoglycemiaInsulinPatientsType 2 diabetesWeight gain ePublished: 3 April 2018 Issue Published: 3 April 2018 Copyright & PermissionsCopyright © 2018 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7326/l17-0706

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 26

Metadata

Authors
Beck, R. W., & Riddlesworth, T. D.
Venue
Annals of Internal Medicine
Published
2018-04-03
Volume
168
Issue
7
Pages
526-527
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2990064316
Cited by
26
References
1
FWCI
2.56
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.